Inducible CYP2J2 and Its Product 11,12-EET Promotes Bacterial Phagocytosis: A Role for CYP2J2 Deficiency in the Pathogenesis of Crohn’s Disease?

作者: Jonas Bystrom , Scott J. Thomson , Jörgen Johansson , Matthew L. Edin , Darryl C. Zeldin

DOI: 10.1371/JOURNAL.PONE.0075107

关键词:

摘要: The epoxygenase CYP2J2 has an emerging role in inflammation and vascular biology. of phagocytosis is not known its regulation human inflammatory diseases poorly understood. Here we investigated the bacterial expression monocytes from healthy controls Crohns disease patients. anti-inflammatory peripheral blood monocytes. Bacterial LPS induced mRNA protein. arachidonic acid products 11,12-EET 14,15-EET inhibited TNFα release. THP-1 were transformed into macrophages by 48h incubation with phorbol 12-myristate 13-acetate. Epoxygenase inhibition using a non-selective inhibitor SKF525A or selective Compound 4, E. coli particle phagocytosis, which could be specifically reversed 11,12-EET. Moreover, reduced receptors CD11b CD68. also mediates L. monocytogenes phagocytosis. Similar, to bioparticle intracellular levels monocytogenes, co-incubation Disrupted clearance hallmark Crohn’s disease. Unlike control donors, patients showed no induction response coli. These results demonstrate that macrophages, implicates defect pathway may regulate

参考文章(41)
Alberto Mantovani,, Antonio Sica,, Massimo Locati, Macrophage Polarization Comes of Age Immunity. ,vol. 23, pp. 344- 346 ,(2005) , 10.1016/J.IMMUNI.2005.10.001
William B. Campbell, Ingrid Fleming, Epoxyeicosatrienoic acids and endothelium-dependent responses Pflügers Archiv - European Journal of Physiology. ,vol. 459, pp. 881- 895 ,(2010) , 10.1007/S00424-010-0804-6
Ma JiXiang Ma JiXiang, S Ramachandran, FT, Jr Fiedorek, DC Zeldin, Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4. Genomics. ,vol. 49, pp. 152- 155 ,(1998) , 10.1006/GENO.1998.5235
Ara Askari, Scott J. Thomson, Matthew L. Edin, Darryl C. Zeldin, David Bishop-Bailey, Roles of the epoxygenase CYP2J2 in the endothelium Prostaglandins & Other Lipid Mediators. ,vol. 107, pp. 56- 63 ,(2013) , 10.1016/J.PROSTAGLANDINS.2013.02.003
Wanying Zhang, Jie Liao, Haonan Li, Hua Dong, Han Bai, Allison Yang, Bruce D. Hammock, Guang-Yu Yang, Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency. Molecular Carcinogenesis. ,vol. 52, pp. 726- 738 ,(2013) , 10.1002/MC.21918
R.F. Harvey, J.M. Bradshaw, A simple index of Crohn's-disease activity. The Lancet. ,vol. 1, pp. 514- 514 ,(1980) , 10.1016/S0140-6736(80)92767-1
Kaspar J Willson, Antony Jacob, Mohit P Shetti, Rajesh Bhatia, Kwang Yee, William Osler, Listeria monocytogenes infection in Crohn's disease treated with adalimumab. The Medical Journal of Australia. ,vol. 197, pp. 466- 467 ,(2012) , 10.5694/MJA11.10521
Kaeko Nakayama, Takeaki Nitto, Teruo Inoue, Koichi Node, Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. Life Sciences. ,vol. 83, pp. 339- 345 ,(2008) , 10.1016/J.LFS.2008.06.026
Shu Wu, Cindy R. Moomaw, Kenneth B. Tomer, John R. Falck, Darryl C. Zeldin, MOLECULAR CLONING AND EXPRESSION OF CYP2J2, A HUMAN CYTOCHROME P450 ARACHIDONIC ACID EPOXYGENASE HIGHLY EXPRESSED IN HEART Journal of Biological Chemistry. ,vol. 271, pp. 3460- 3468 ,(1996) , 10.1074/JBC.271.7.3460
Pierre Lafite, Sylvie Dijols, Darryl C. Zeldin, Patrick M. Dansette, Daniel Mansuy, Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2. Archives of Biochemistry and Biophysics. ,vol. 464, pp. 155- 168 ,(2007) , 10.1016/J.ABB.2007.03.028